Prevention of congenital toxoplasmosis in a Buenos Aires hospital;Prevención de la toxoplasmosis congénita en un hospital de Buenos Aires

Medicina (Argentina)

Volumn 73, Issue 3, 2013, Pages 238-242

  Carral, Liliana ^a   Kaufer, Federico ^a   Olejnik, Patricia ^a   Freuler, Cristina ^a   Durlach, Ricardo ^a  

^a HOSPITAL ALEMÁN   (Argentina)

Author keywords

Congenital toxoplasmosis; Prevention; Serology

Indexed keywords

ANTIBODY;

ARTICLE; BIRTH; CHORIORETINITIS; CONGENITAL INFECTION; CONGENITAL TOXOPLASMOSIS; DISEASE SEVERITY; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; PLACENTAL TRANSFER; PREGNANT WOMAN; STRABISMUS; TOXOPLASMA GONDII; VERTICAL TRANSMISSION;

CONGENITAL TOXOPLASMOSIS; PREVENTION; SEROLOGY;

ANTIBODIES, PROTOZOAN; ARGENTINA; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GOVERNMENT PROGRAMS; HUMANS; IMMUNOGLOBULINS; IMMUNOSORBENT TECHNIQUES; INCIDENCE; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PROSPECTIVE STUDIES; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 84884953168     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. th ed. Philadelphia: Elsevier-Saunders Company 2006; p 947-1091.
2. Gómez-Marin JE, de-la-Torre A, Angel-Muller E, et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis 2011; 5: 1195.
3. Aspöck H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992; S84: 32-37.
4. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008; 47: 554-566.
5. Thulliez P. Screening program for congenital toxoplas-mosis in France. Scand J Infect Dis 1992; S84: 43-45.
6. Empfehlungen für die Durchführung der Toxoplasma-Sero-reaktionen mittels Mikromethode. Bundesgesundheitsblatt 1977; 20: 108-112.
7. Desmonts G, Naot Y, Remington JS. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol 1981; 14: 486-491.
8. Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy an epidemiologic survey over 22 consecutive years. J Perinat Med 2004; 32: 211-214.
9. Durlach R, Kaufer F, Carral L, Hirt J. Toxoplasmic lymphadenitis-clinical and serologic profile. Clin Microbiol Infect 2003; 9: 625-631.
10. Saathoff M, Seitz HM. Detection of toxoplasma-specific IgA and IgM antibodies in serum samples of adults with acquired toxoplasma infection. Z Geburtshilfe Perinatol. 1992; 196: 221-223.
11. Gross U, Keksel O, Dardé ML. Value of detecting immu-noglobulin E antibodies for the serological diagnosis of Toxoplasma gondii infection. Clin Diagn Lab Immunol 1997; 4: 247-251.
12. Hirt J. Diagnóstico. En: Hirt J.(ed) Toxoplasmosis. 1era ed. Buenos Aires: El Ateneo, 1974, p 45-58.
13. Press C, Montoya JG, Remington JS. Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. J Clin Microbiol 2005; 43: 3453-3481.
14. Bessières MH, Berrebi A, Rolland M, et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and infuence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol 2001; 94: 37-45.
15. Burg IL, Grover CM, Pouletty P, Boothroyd IC. Direct and sensitive detection of a pathogenic protozoan, Toxoplas-ma gondii, by polymerase chain reaction. J Clin Microbiol 1989; 27: 1787-1792.
16. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004; 363: 1965-1976.
17. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 2001; 183: 1248-1253.
18. Candolf E, Pastor R, Huber R, Filisetti D, Villard O. IgG avidity assay frms up the diagnosis of acute toxoplas-mosis on the frst serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis 2007; 58: 83-88.
19. Desmonts G, Couvreur J. Congenital toxoplasmosis: a prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy: pathophysiology of congenital disease. In: Thalhammer O, Baumgarten K, Pollak A (eds). Perinatal medicine, Sixth European Congress, Vienna. Stuttgart. Georg Thieme 1979; p 51-60.
20. Thulliez P. Maternal and foetal infection. In: Joynson D. and Wreghitt (eds). Cambridge University Press. Toxoplasmo-sis, a comprehensive clinical guide 2001; p 193-201.
21. Minkoff H, Remington JS, Holman S, Ramirez R, Goodwin S, Landesman S. Vertical transmission of Toxoplasma by human immunodeficiency virus-infected women. Am J Obstet Gynecol 1997; 176: 555-559.
22. Bachmeyer C, Mouchnino G, Thulliez P, Blum L. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation. J Infect 2006; 52: 55-57.
23. Azevedo KM, Setúbal S, Lopes VG, Camacho LA, Oliveira SA. Congenital toxoplasmosis transmitted by human immunodeficiency-virus infected women. Braz J Infect Dis 2010; 14: 186-189
24. Villena I, Ancelle T, Delmas C, et al. Congenital toxoplasmo-sis in France in 2007: first results from a national surveillance system. Toxosurv network and National Reference Centre for Toxoplasmosis. Euro Surveill. 2010; 24: 15.
25. de Melo Inagaki AD, Carvalheiro CG, Cipolotti R et al. Birth prevalence and characteristics of congenital toxo-plasmosis in Sergipe, North-east Brazil. Trop Med Int Health 2012 doi: 10.1111/j.1365-3156.2012.03079Sep 14.1365-3156.
26. Carvalheiro CG, Mussi-Pinhata MM, Yamamoto AY, De Souza CB, Maciel LM. Incidence of congenital toxoplas-mosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiol Infect 2005; 133: 485-491.
27. Bichara CN, Canto GA, Tostes C de L, et al. Incidence of congenital toxoplasmosis in the City of Belém, State of Pará, Northern Brazil, determined by a neonatal screening program: preliminary results. Rev Soc Bras Med Trop 2012; 45: 122-124.
28. Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 2011; 30: 1056-1061.
29. Sauer A, de la Torre A, Gomez-Marin J, et al. Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America. Pediatr Infect Dis J 2011; 30: 601-603.
30. Ajzenberg D. Unresolved questions about the most successful known parasite. Expert Rev Anti Infect Ther 2011; 9: 169-171.
31. Durlach R, Kaufer F, Carral L, et al. Consenso argentino de toxoplasmosis congénita. Medicina (B Aires) 2008; 68: 75-87.
32. Carral L, Kaufer F, Durlach R, et al. Estudio multicéntrico para la prevención de la toxoplasmosis prenatal en Buenos Aires. Medicina (B Aires) 2008; 68: 417-422.
33. Robert-Gangneux F, Dupretz P, Yvenou C et al. Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 2010; 29: 33-38.
34. Fricker-Hidalgo H, Brenier-Pinchart MP, Schaal JP, et al. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 2007; 26: 845-846.